On the evening of December 31, 2025, the management team of Benefite Pharma gathered in the meeting room on the third floor of the company to watch Luo Zhenyu's New Year's Eve speech "Friends of Time 2026". Centered on the theme of "The World in 1000 Days", the in-depth discussion on the development trend of AI is highly consistent with Benefite Pharma’s original aspiration to deepen its roots in the pharmaceutical and healthcare sector. Moreover, the concept of "aspiration" that runs through the speech has become the core key for us to decode the future.

Outside the window lay a cold winter night, yet the room was filled with fervent anticipation for the future. As the New Year bell tolled, the managers of Benefite Pharma not only ushered in the year 2026, but also embarked on a ideological journey exploring how to navigate the AI era with aspiration.

01 A Feast of Ideas: Forging Consensus at a Turning Point of the Times

At 8:30 p.m., the meeting room was packed to capacity. On the large screen, Luo Zhenyu's speech kicked off as scheduled. For the hours that followed, the entire audience maintained intense focus, with everyone immersed in reflections on the trends of the intelligence-augmented era. Luo Zhenyu's incisive yet accessible analyses and forward-looking insights into the future prompted frequent nods and diligent note-taking from the managers present. In particular, when the speech touched upon three core questions—"Will I be replaced by AI?" "Where does my competitiveness come from?" and "What will things be like in 1000 days?"—it sparked a profound, silent resonance of thoughts among the attendees.

02 Will I Be Replaced by AI? 

The Answer is "Empowerment" Rather Than "Replacement"

This is an unavoidable anxiety across every industry and for every individual today. The answer Luo Zhenyu provided in his speech acted like a reassuring tonic: "The essence of AI is to lift humans up, not to push them out." Its profound implication lies in this: technology is not a replacement, but a lever to reshape value. With data as the fulcrum, it will free humanity from repetitive tasks, allowing wisdom and energy to be focused on higher-level innovation, insight, and humanistic care. This is not only the direction pointed out by Mr. Luo Zhenyu, but also a firm conviction for managers in navigating changes—instead of worrying about replacement, we should focus on how to leverage AI to empower teams toward a realm of irreplaceable creativity.

03 Where Does My Competitiveness Come From?

Aspiration as the Core, AI as the Wings

"In an era where AI logic and computing power far surpass those of humans, what exactly defines the uniqueness of human beings?" The answer Luo Zhenyu gave—"aspiration"—struck a deep chord in the hearts of all Benefite employees. Aspiration, as defined here, is not blind perseverance; it is the dedication to "strive wholeheartedly with sufficient subjective basis and unwavering objective resolve." It is the firm resolve to forge ahead against all odds, knowing full well that pharmaceutical R&D is a painstaking process that takes "ten years to sharpen a single sword." It is the commitment to always uphold the original aspiration of "protecting life and health," unshaken by short-term gains.

If AI is an "accelerator" bestowed by the times, then aspiration is Benefite's "compass." Without aspiration, AI is merely a cold technological tool; without AI, the realization of aspiration would be an arduous journey. Only by taking aspiration as the core and AI as the wings can we forge a distinctive path in the fierce industry competition that aligns with both the trends of the times and the original aspiration of the enterprise.

04 What Will Things Be Like in 1000 Days? 

Marching Forward to the Future with Aspiration, Growing Together with AI

Luo Zhenyu said that 1000 days is "a time frame that is both foreseeable and transformative enough." Standing at the starting point of 2026, integrating Luo Zhenyu's forward-looking insights with Benefite's development plan, we have a clear vision of the future 1000 days from now—it will be a new pharmaceutical ecosystem characterized by "the deep integration of aspiration and AI."

In the world 1000 days from now, AI may bring more unexpected changes, but Benefite's original aspiration will remain unchanged—to anchor ourselves in aspiration and safeguard life and health; to take AI as our wings and explore the future of the industry. Benefite firmly believes that as long as we uphold aspiration and make good use of AI, we will emerge as pioneers who "remain unshaken and even lead the way" in the tides of the times.

05 2026: Let Aspiration Be the Light, March Forward to the Future

As the lights of New Year's Eve dimmed, the direction in our hearts became increasingly clear. Luo Zhenyu's speech made us understand that AI is a tool, a partner, and even wings to lift us toward a more distant future, while aspiration is the core driving force that propels us forward.

In 2026, Benefite Pharma will carry this reverence and dedication to life and health, take aspiration as the light and AI as the wings, and forge ahead steadfastly on the path of pharmaceutical innovation. We believe that the beauty of the world 1000 days from now lies in every down-to-earth effort we make today; and the future of the pharmaceutical industry will ultimately belong to those pioneers who understand technology yet embrace warmth, follow trends yet stay true to their original aspirations.

In the new year, let us march forward hand in hand, embrace the future with aspiration, and jointly write a new chapter for the pharmaceutical industry 1000 days from now!